 |
ASPIRAS – the development services integrator
Time is the key factor in bringing a new drug to the market. Finishing on time can decide the profitability of a program. Therefore the size of the team has to fit the program. External resources can help to bridge shortages in order to avoid delays in the schedule due to a lean own manpower. The cooperation with external partners who are prepared to share laboratory competences can help to accelerate the project significantly.
Venture manpower: as important as venture capital
Since the end of the investment boom in biotech and pharma companies, the raising of venture capital has become more challenging. In addition, pharmaceutical companies’ growth is driven by R&D of new products, which requires more manpower as well as more capital, says Cathrin Pauly of ASPIRAS.
euro-biotech
Pharma meets Biotechnology, 2003
ASPIRAS – the development services integrator
Time is the key factor in bringing a new drug to the market. Finishing on time can decide the profitability of a program. Therefore the size of the team has to fit the program. ...
SCRIP
World Pharmaceutical News, July 12th 2002
A new German drug development consultancy, Aspiras:
A new German consultancy, Aspiras, has been set up in Mainz to facilitate drug development project
